We are live on ! Find out more
FCSC

Fibrocell Science Inc.
FCSC

Delisted

FCSC was delisted on the 12th of December, 2019.

44 hedge funds and large institutions have $31.4M invested in Fibrocell Science Inc. in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

15% less funds holding

Funds holding: 5244 (-8)

27% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 15

47% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 17

58% less capital invested

Capital invested by funds: $75.4M → $31.4M (-$44M)

Holders
44
Holders Change
-8
Holders Change %
-15.38%
% of All Funds
1.17%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
9
Increased
11
Reduced
15
Closed
17
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TS
1
Third Security
Virginia
$19.1M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$3M -$579K -18,576 -10%
MP
3
MSD Partners
New York
$2.39M
QF
4
QVT Financial
New York
$2.2M
Vanguard Group
5
Vanguard Group
Pennsylvania
$1.49M -$132K -4,244 -5%
Janney Montgomery Scott
6
Janney Montgomery Scott
Pennsylvania
$398K +$486K +15,599 +209%
OAM
7
Oxford Asset Management
United Kingdom
$361K +$245K +7,868 +60%
Cambridge Investment Research Advisors
8
Cambridge Investment Research Advisors
Iowa
$288K +$124K +3,995 +31%
Jacobs Levy Equity Management
9
Jacobs Levy Equity Management
New Jersey
$210K +$347K +11,127 +1,050%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$206K -$58.5K -1,878 -14%
HVC
11
Healthcare Value Capital
New Jersey
$170K
Goldman Sachs
12
Goldman Sachs
New York
$163K +$226K +7,269 +337%
BIT
13
BlackRock Institutional Trust
California
$157K -$368K -11,815 -57%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$130K -$156K -5,002 -40%
California Public Employees Retirement System
15
California Public Employees Retirement System
California
$125K
SCA
16
STALEY CAPITAL ADVISERS
Pennsylvania
$113K
PP
17
Paloma Partners
Connecticut
$111K +$201K +6,450 New
CS
18
Credit Suisse
Switzerland
$101K +$156K +5,013 +605%
Morgan Stanley
19
Morgan Stanley
New York
$81K +$17K +547 +13%
BFA
20
BlackRock Fund Advisors
California
$70K -$1.24M -39,796 -91%
LP
21
LMR Partners
United Kingdom
$66K +$120K +3,847 New
ARTA
22
A.R.T. Advisors
New York
$65K +$118K +3,803 New
FSA
23
Franklin Street Advisors
North Carolina
$58K
Millennium Management
24
Millennium Management
New York
$53K +$96K +3,082 New
SIP
25
Stoneridge Investment Partners
Pennsylvania
$50K

FCSC Hedge Fund Activity: Q2 2016 in Review

44 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Fibrocell Science Inc. (FCSC) for Q2 2016, worth a combined $31.4M — down 58% from $75.4M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of FCSC and 9 opened new positions — a net loss of 8 holders — while 15 trimmed existing stakes and 11 added.

The largest buyer was Janney Montgomery Scott, adding an estimated $486K. The largest seller was Jennison Associates, exiting entirely with an estimated $4.78M sold.

  • 44 institutional investors held Fibrocell Science Inc. (FCSC) as of Q2 2016, down from 52 in Q1 2016.
  • Funds reported $31.4M of Fibrocell Science Inc. stock for Q2 2016, down 58% quarter-over-quarter.
  • 9 funds opened new Fibrocell Science Inc. positions in Q2 2016 and 17 closed out, a net change of -8 holders.
  • The largest Fibrocell Science Inc. buyer in Q2 2016 was Janney Montgomery Scott, an estimated $486K added.
  • The largest Fibrocell Science Inc. seller in Q2 2016 was Jennison Associates, an estimated $4.78M sold.

Based on aggregated 13F filings for Q2 2016.